Supportive to our results are the results by Martin-Cordero et al. of increased levels of IL-6 in high CV risk rats (genetically obese rats with metabolic syndrome)[27], and the study by Zhou et al. which found increased levels of IL-6 in epicardial tissue in humans with CAD[28], highlighting this association. Here, IL6 is linked to coronary artery disorder.